Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Peptide vaccine targeting mutatedGNAS: a potential novel treatment for pseudomyxoma peritonei
Kjersti Flatmark, Annette Torgunrud, Karianne G. Fleten, et al.
Journal for ImmunoTherapy of Cancer (2021) Vol. 9, Iss. 10, pp. e003109-e003109
Open Access | Times Cited: 18

Showing 18 citing articles:

Precision Oncology and Systemic Targeted Therapy in Pseudomyxoma Peritonei
Jordi Martínez‐Quintanilla, Débora Cabot, Doménico Sabia, et al.
Clinical Cancer Research (2024) Vol. 30, Iss. 18, pp. 4082-4099
Open Access | Times Cited: 5
Progress in Biological Research and Treatment of Pseudomyxoma Peritonei
Xi Li, Guodong Liu, Wei Wu
Cancers (2024) Vol. 16, Iss. 7, pp. 1406-1406
Open Access | Times Cited: 4
Distinct gene signatures define the epithelial cell features of mucinous appendiceal neoplasms and pseudomyxoma metastases
Carlos Ayala, Anuja Sathe, Xiangqi Bai, et al.
Frontiers in Genetics (2025) Vol. 16
Open Access
Contract to kill: GNAS mutation
Pratima Raut, Poompozhil Mathivanan, Surinder K. Batra, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access
Case Report: Insights into multiple cases of Pseudomyxoma peritonei
H Y Chu, XiaoBiao Song
Frontiers in Gastroenterology (2025) Vol. 4
Open Access
The genetic profile and molecular subtypes of human pseudomyxoma peritonei and appendiceal mucinous neoplasms: a systematic review
Nora Wangari Murage, Nada Ahmed, Timothy J. Underwood, et al.
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 1, pp. 335-359
Open Access | Times Cited: 9
Progress on immuno-microenvironment and immune-related therapies in patients with pseudomyxoma peritonei
Qidi Zhao, Wei Tian, Ru Ma, et al.
Cancer Biology and Medicine (2024), pp. 1-20
Open Access | Times Cited: 2
Going Rogue: Mechanisms, Regulation, and Roles of Mutationally Activated Gαin Human Cancer
Morgan Dwyer, Jenna Aumiller, Philip Wedegaertner
Molecular Pharmacology (2024) Vol. 106, Iss. 5, pp. 198-215
Closed Access | Times Cited: 2
Landscape of Genetic Mutations in Appendiceal Cancers
Marian Constantin, Cristina Mătanie, Livia Petrescu, et al.
Cancers (2023) Vol. 15, Iss. 14, pp. 3591-3591
Open Access | Times Cited: 6
Serum and ascites tumor markers in the diagnostic and prognostic prediction for appendiceal pseudomyxoma peritonei
Bing Wang, Ruiqing Ma, Benqiang Rao, et al.
BMC Cancer (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 5
Comprehensive Understanding and Evolutional Therapeutic Schemes for Pseudomyxoma Peritonei
Suiting Ye, Song Zheng
American Journal of Clinical Oncology (2022) Vol. 45, Iss. 5, pp. 223-231
Open Access | Times Cited: 6
Mytomicin-C, Metronomic Capecitabine, and Bevacizumab in Patients With Unresectable or Relapsed Pseudomyxoma Peritonei of Appendiceal Origin
Filippo Ghelardi, Alessandra Raimondi, Federica Morano, et al.
Clinical Colorectal Cancer (2023) Vol. 22, Iss. 4, pp. 450-456.e1
Closed Access | Times Cited: 3
Whole-Exome Sequencing Identifies Mutation Profile and Mutation Signature-Based Clustering Associated with Prognosis in Appendiceal Pseudomyxoma Peritonei
Yu‐Lin Lin, Jun-Qi Zhu, Ruiqing Ma, et al.
Molecular Cancer Research (2023) Vol. 22, Iss. 1, pp. 70-81
Closed Access | Times Cited: 3
Appendix Neoplasms
Paul Sutton, Sarah O’Dwyer
Coloproctology (2024), pp. 147-177
Closed Access
Exploring the Patient Experience Through Qualitative Methods: The Missing Piece of Cytoreductive Surgery and HIPEC Research
Erin Ward, Alissa Greenbaum
Annals of Surgical Oncology (2024) Vol. 31, Iss. 12, pp. 7679-7681
Open Access
New insights in the management of pseudomyxoma peritonei
Clément Pastier, Ignace H. J. T. de Hingh, Diane Goèré
Journal of Surgical Oncology (2024)
Open Access
Therapy of genomic unstable solid tumours (WHO grade 3/4）in clinical stage III/IV using individualised neoantigen tumour peptides-INP trial (individualised neoantigen tumour peptides immunotherapy): study protocol for an open-label, non-randomised, prospective, single-arm trial
Ling Wang, Jia-Xi Tang, Xia Chen, et al.
BMJ Open (2022) Vol. 12, Iss. 6, pp. e055742-e055742
Open Access | Times Cited: 2
Distinct cell states define the developmental trajectories of mucinous appendiceal neoplasms towards pseudomyxoma metastases
Carlos Ayala, Anuja Sathe, Xiangqi Bai, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 1
Page 1

Scroll to top